BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 2994355)

  • 1. [Rhinopharyngeal carcinoma and Epstein-Barr virus: study of a sample of Italian patients].
    Caliceti U; Cevenini R; Donati M
    Acta Otorhinolaryngol Ital; 1985; 5(1):83-90. PubMed ID: 2994355
    [No Abstract]   [Full Text] [Related]  

  • 2. [Humoral response to Epstein-Barr virus of patients with nasopharyngeal cancer and its use in the differential diagnosis of the disease].
    Gurtsevich VE; Plakhov IV; Chuĭkina NA; Abdulin NA
    Vestn Akad Med Nauk SSSR; 1984; (5):29-34. PubMed ID: 6331022
    [No Abstract]   [Full Text] [Related]  

  • 3. Anti-EBV antibody titers in Italian patients with nasopharyngeal carcinoma.
    Pirodda E; Caliceti U; Testoni S
    J Exp Pathol; 1987; 3(4):479-83. PubMed ID: 2842481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr virus-related serology in nasopharyngeal carcinoma and controls.
    Henle W; Henle G; Ho JH
    IARC Sci Publ (1971); 1978; (20):427-37. PubMed ID: 215525
    [No Abstract]   [Full Text] [Related]  

  • 5. Serological markers in the diagnosis of histopathological types of nasopharyngeal carcinoma.
    Sam CK; Prasad U; Pathmanathan R
    Eur J Surg Oncol; 1989 Aug; 15(4):357-60. PubMed ID: 2547665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus specific antibodies in patients with IgA nephropathy.
    Wu AY; Lau YK; Chia KB; Lim CH
    Singapore Med J; 1988 Jun; 29(3):257-60. PubMed ID: 2847323
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies of the Epstein-Barr herpesvirus relationship with Hodgkin's disease and the use of virus immunological markers in differential diagnostics of nasopharyngeal carcinoma.
    Mazurenko NP; Gurtsevich VE; Stepina VN; Plakhov IV
    Arch Geschwulstforsch; 1983; 53(3):253-9. PubMed ID: 6311138
    [No Abstract]   [Full Text] [Related]  

  • 8. Squamous carcinoma of the nasopharynx.
    Moloy PJ; Chung YT; Krivitsky PB; Kim RC
    West J Med; 1985 Jul; 143(1):66-9. PubMed ID: 2994305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nasopharyngeal carcinoma: significance of changes in Epstein-Barr virus-related antibody patterns following therapy.
    Henle W; Ho JH; Henle G; Chau JC; Kwan HC
    Int J Cancer; 1977 Nov; 20(5):663-72. PubMed ID: 200569
    [No Abstract]   [Full Text] [Related]  

  • 10. Prognostic value of anti-Epstein-Barr virus antibodies in nasopharyngeal carcinoma (NPC).
    Liu MT; Yeh CY
    Radiat Med; 1998; 16(2):113-7. PubMed ID: 9650898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies to Epstein-Barr virus in nasopharyngeal carcinoma, tonsillar carcinoma and control groups.
    Oberender H; Nowak R; Donner A; Kunkel M; Gärtner L; Scholtz HJ
    Acta Virol; 1983 May; 27(3):277-81. PubMed ID: 6138990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Lymphoepithelial carcinoma of the nasopharynx: a special tumor?].
    Meister P; Nathrath W; Wilmes E; Wolf H
    Verh Dtsch Ges Pathol; 1981; 65():171-5. PubMed ID: 6289547
    [No Abstract]   [Full Text] [Related]  

  • 13. Epstein-Barr virus seroepidemiology in China.
    Zeng Y; Pi GH; Deng H; Zhang JM; Wang PC; Wolf H; De Thé G
    AIDS Res; 1986 Dec; 2 Suppl 1():S7-15. PubMed ID: 3030349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Tonsillar cancer and Epstein-Barr virus].
    Wilmes E; Wolf H; Haus M
    Laryngol Rhinol Otol (Stuttg); 1983 Dec; 62(12):586-9. PubMed ID: 6323895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The epidemiology of EBV-associated malignant diseases.
    Levine PH
    J Exp Pathol; 1987; 3(4):437-9. PubMed ID: 2842475
    [No Abstract]   [Full Text] [Related]  

  • 16. Presence of Epstein-Barr virus specific IgA in saliva of nasopharyngeal carcinoma patients: their activity, origin and possible clinical value.
    Desgranges C; de-The G
    IARC Sci Publ (1971); 1978; (20):459-69. PubMed ID: 215528
    [No Abstract]   [Full Text] [Related]  

  • 17. Nasopharyngeal carcinoma due to Epstein-Barr virus: serologic tests.
    Smith TF
    Mayo Clin Proc; 1985 Mar; 60(3):205-6. PubMed ID: 2983152
    [No Abstract]   [Full Text] [Related]  

  • 18. [Value of anti-Epstein-Barr antibody detection in the diagnosis and management of undifferentiated carcinoma of the nasopharynx].
    Mazeron MC
    Bull Cancer Radiother; 1996; 83(1):3-7. PubMed ID: 8679277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nasopharyngeal carcinoma: Epstein-Barr Virus significance.
    Kottaridis SD; Panotopoulou E; Diamantis I; Goula I; Danilidis J; Fountzilas G
    Anticancer Res; 1996; 16(2):785-9. PubMed ID: 8687129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Nasopharyngeal carcinoma: clinical and therapeutic aspects. I. Introduction and symptomatology].
    Vilas Melero J; Vilas Melero J; Vilas Ribot J; Montserrat Viladiu MJ
    An Otorrinolaringol Ibero Am; 1984; 11(1):19-37. PubMed ID: 6089603
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.